A Life Course Approach to Investigating Asthma Pathogenesis and Progression
研究哮喘发病机制和进展的生命全程方法
基本信息
- 批准号:G0900453-E01/1
- 负责人:
- 金额:$ 275.04万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Asthma is the commonest chronic lung disease in the UK. It affects all age groups and significantly impacts on quality of life, schooling and work. For most it requires lifelong treatment with drugs and uncertainty, due to the variable nature of the disease. Little is known how factors initiate the disease in early life or impact over the life course of the disease. This programme is centred on studying the life course of asthma, focusing on underlying mechanisms that may lead to disease persistence and progression and how different environmental factors exert influence.Our research focuses on the human asthma and involves sampling the airways to evaluate on-going tissue events and to obtain airway cells that can be studied in the laboratory under different conditions of exposure. We believe that the airways lining (epithelium) plays a major role in interacting with the environment and, in asthma, expresses signals that promote abnormal inflammation within the airways and induce structural changes (scarring) that alters their flexibility. We have called this dynamic interaction between the epithelium and the deeper airway wall structures the Epithelial Mesenchymal Trophic Unit (EMTU). Our research focuses on understanding how this EMTU is activated in asthma of differing severity and stages of disease. Recognising that most asthma has its origin in the first few years of life, undergoes major changes during childhood and adolescence in which over half ?grow out? of their diseases and adopts characteristics of becoming irreversible in some adults, we have constructed our 5 year programme in 3 stages: (i) In young children at the onset of disease we will use our cell culture systems in the presence and absence of virus, allergen and tobacco smoke exposure to seek differences in the way the epithelium communicates with underlying cells in the EMTU; ii) In teenagers from our Isle of Wight cohort, that has been extensively characterised in relationship to asthma from birth to the age of 18 years, we will assess activation of the EMTU in those with persistent asthma and those who have ?grown out? of asthma; and (iii) In adults with established asthma we determine how the scarring affects the stiffness of the airway wall and whether repeated airway narrowing contributes to and can account for the loss of treatment response in such asthmatics.This research will identify much needed new targets in disease prevention and treatment high up in the causal disease pathways.
哮喘是英国最常见的慢性肺部疾病。它影响所有年龄段,并对生活质量,学校和工作产生重大影响。对于大多数人来说,由于疾病的性质可变,因此需要用药物和不确定性治疗。知之甚少,因素如何在早期生命中引发该疾病或在疾病的生活过程中影响。该计划集中在研究哮喘的生命过程中,重点关注可能导致疾病持久性和进展的潜在机制,以及不同的环境因素如何发挥影响。我们认为,气道衬里(上皮)在与环境相互作用中起着重要作用,并且在哮喘中表达了促进气道内异常炎症的信号,并引起结构变化(疤痕),从而改变了它们的灵活性。我们称上皮和较深的气道壁之间的这种动态相互作用是上皮间质营养单元(EMTU)。我们的研究重点是了解这种EMTU在不同严重程度和疾病阶段的哮喘中如何激活。认识到大多数哮喘在生命的头几年起起源,在儿童时期和青春期发生了重大变化,超过一半?在某些成年人中,它们的疾病并采用了变得不可逆转的特征,我们已经在3个阶段构建了我们的5年计划:(i)在疾病发作时,在幼儿中,我们将在病毒,过敏原和烟草烟雾的存在下使用我们的细胞培养系统,以与上皮相处的emplys smoge smoke smoke the Emtuce cell inemtu smecly segrance seking neemtu cell in emtu cell in emtu cell in emtube cell; ii)在我们怀特岛队列的青少年中,从出生到18岁的哮喘的关系中,这是广泛的特征,我们将评估EMTU在患有持续性哮喘的人中的激活,并且已经成长了?哮喘(iii)在患有已建立哮喘的成年人中,我们确定疤痕如何影响气道壁的僵硬,以及反复的气道狭窄是否有助于并可以解释哮喘患者的治疗反应丧失。这项研究将确定在因果疾病途径中急需的疾病预防和治疗方面的急需新目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Stephen Holgate其他文献
Efficacy of omalizumab in allergic asthma patients at high-risk for asthma-related death
- DOI:10.1016/s0091-6749(02)81596-210.1016/s0091-6749(02)81596-2
- 发表时间:2002-01-012002-01-01
- 期刊:
- 影响因子:
- 作者:Jean Bousquet;Stephen Holgate;Howard Fox;Jeen Liu;Jordi CastellsagueJean Bousquet;Stephen Holgate;Howard Fox;Jeen Liu;Jordi Castellsague
- 通讯作者:Jordi CastellsagueJordi Castellsague
Clearing the air: Assessing healthcare professionals' awareness of air pollution's health consequences
- DOI:10.1016/j.fhj.2024.10013010.1016/j.fhj.2024.100130
- 发表时间:2024-06-012024-06-01
- 期刊:
- 影响因子:
- 作者:Lydia Holtgrewe;Dahye Yoon;Christopher Johnes;Stephen Holgate;Lia Orlando;James Bevan;Yasmin Choudhury;Charlotte Soan;Thomas DanielsLydia Holtgrewe;Dahye Yoon;Christopher Johnes;Stephen Holgate;Lia Orlando;James Bevan;Yasmin Choudhury;Charlotte Soan;Thomas Daniels
- 通讯作者:Thomas DanielsThomas Daniels
Inhaled corticosteroid dose-reducing effect of omalizumab in patients with controlled, severe asthma according to usage of inhaled long-acting beta-agonists
- DOI:10.1016/s0091-6749(02)81861-910.1016/s0091-6749(02)81861-9
- 发表时间:2002-01-012002-01-01
- 期刊:
- 影响因子:
- 作者:Kian Fan Chung;Stephen Holgate;John O'Brien;Howard Fox;Jackie ThirlwellKian Fan Chung;Stephen Holgate;John O'Brien;Howard Fox;Jackie Thirlwell
- 通讯作者:Jackie ThirlwellJackie Thirlwell
Maintenance of Skills, Competencies, and Performance in Allergy and Clinical Immunology: Time to Lay the Foundation for a Universal Approach
- DOI:10.1097/wox.0b013e31825546b410.1097/wox.0b013e31825546b4
- 发表时间:2012-01-012012-01-01
- 期刊:
- 影响因子:
- 作者:Todor A. Popov;Dennis Ledford;Richard Lockey;Ruby Pawankar;James T. Li;Hae Sim Park;Werner Pichler;Noel Rodriguez Perez;Paolo Tassinari;Fulvio Braido;Sami Bahna;Dirceu Solé;Connie Katelaris;Stephen Holgate; on behalf of the World Allergy Organization Education CouncilTodor A. Popov;Dennis Ledford;Richard Lockey;Ruby Pawankar;James T. Li;Hae Sim Park;Werner Pichler;Noel Rodriguez Perez;Paolo Tassinari;Fulvio Braido;Sami Bahna;Dirceu Solé;Connie Katelaris;Stephen Holgate; on behalf of the World Allergy Organization Education Council
- 通讯作者:on behalf of the World Allergy Organization Education Councilon behalf of the World Allergy Organization Education Council
Time-course study of change in sputum cellularity and airway responsiveness to AMP and methacholine after budesonide
- DOI:10.1016/s0091-6749(02)81207-610.1016/s0091-6749(02)81207-6
- 发表时间:2002-01-012002-01-01
- 期刊:
- 影响因子:
- 作者:Gaetano Prosperini;Karalasingam Rajakulasingam;Maria Sarvà;Rossella Cacciola;Stephen Holgate;Riccardo PolosaGaetano Prosperini;Karalasingam Rajakulasingam;Maria Sarvà;Rossella Cacciola;Stephen Holgate;Riccardo Polosa
- 通讯作者:Riccardo PolosaRiccardo Polosa
共 7 条
- 1
- 2
Stephen Holgate的其他基金
Wave 2 support for SPF Clean Air Champions - "Addressing the Challenge of the Indoor/Outdoor Continuum"
对 SPF 清洁空气冠军的第二波支持 - “应对室内/室外连续体的挑战”
- 批准号:NE/X004236/1NE/X004236/1
- 财政年份:2022
- 资助金额:$ 275.04万$ 275.04万
- 项目类别:Research GrantResearch Grant
Application for Strategic Priorities Fund: Clean Air Champion
战略优先基金申请:清洁空气冠军
- 批准号:NE/T002069/1NE/T002069/1
- 财政年份:2019
- 资助金额:$ 275.04万$ 275.04万
- 项目类别:Research GrantResearch Grant
相似国自然基金
面向在线开放课程的捆绑推荐方法研究
- 批准号:72301112
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于图谱补全与评价循证的中学STEM课程资源智能组织方法研究
- 批准号:62307023
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开放环境下大规模缺失数据的鲁棒学习方法与应用
- 批准号:61876127
- 批准年份:2018
- 资助金额:62.0 万元
- 项目类别:面上项目
基于稳健学习机制的复杂场景弱监督目标检测方法研究
- 批准号:61876140
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
大规模开放课程数据中因果关系挖掘方法研究
- 批准号:61877050
- 批准年份:2018
- 资助金额:45.0 万元
- 项目类别:面上项目
相似海外基金
An Integrated Life-course Approach for Person-centred Solutions and Care for Ageing with Multi-morbidity in the European Regions - STAGE; Stay Healthy Through Ageing
欧洲地区以人为本的解决方案和针对多种疾病的老龄化护理的综合生命全程方法 - STAGE;
- 批准号:1011278710112787
- 财政年份:2024
- 资助金额:$ 275.04万$ 275.04万
- 项目类别:EU-FundedEU-Funded
An Integrated Life-Course Approach for Person-Centred Solutions and Care for Ageing with Multimorbidity in the European Regions - STAGE; Stay Healthy Through Ageing (STAGE)
欧洲地区以人为本的解决方案和多病态老龄化护理的综合生命全程方法 - STAGE;
- 批准号:1010995710109957
- 财政年份:2024
- 资助金额:$ 275.04万$ 275.04万
- 项目类别:EU-FundedEU-Funded
A life course approach to explore the social determinants of noncommunicable diseases risks in rural Vietnam
采用生命全程方法探索越南农村非传染性疾病风险的社会决定因素
- 批准号:22KJ316222KJ3162
- 财政年份:2023
- 资助金额:$ 275.04万$ 275.04万
- 项目类别:Grant-in-Aid for JSPS FellowsGrant-in-Aid for JSPS Fellows
A life course approach to understanding ADHD among women
了解女性多动症的生命历程方法
- 批准号:MR/X02220X/1MR/X02220X/1
- 财政年份:2023
- 资助金额:$ 275.04万$ 275.04万
- 项目类别:Research GrantResearch Grant
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:1060340810603408
- 财政年份:2023
- 资助金额:$ 275.04万$ 275.04万
- 项目类别: